The role of inflammation and leukocytes in the pathogenesis of sickle cell disease

Hematology

Volumn 5, Issue 5, 2001, Pages 403-412

  Wun, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Monocytes; Neutrophils; Sickle cell; Vascular disease

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN S; HYDROXYUREA; MARKER; SERUM AMYLOID A; STEROID; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE DISEASE; ARTICLE; BLOOD FLOW; BLOOD VESSEL INJURY; BLOOD VESSEL OCCLUSION; CELL ADHESION; CHRONIC DISEASE; CHRONIC INFLAMMATION; ENDOTHELIUM; ERYTHROCYTE; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE; LEUKOCYTOSIS; LYMPHOCYTE ACTIVATION; MONOCYTE; MORBIDITY; MORTALITY; NEUTROPHIL; PATHOGENESIS; POLYMERIZATION; PREDICTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STEROID THERAPY; STROKE; VASCULITIS;

EID: 0035072888     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Sickle cell anemia, a molecular disease
2. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions
3. Pathogenesis and treatment of sickle cell disease
4. Cerebrovascular accidents in sickle cell disease: Rates and risk factors
5. Stroke prevention in sickle cell disease (STOP): Baseline characteristics of trial patients
6. Mortality in sickle cell disease. Life expectancy and risk factors for early death
7. The acute chest syndrome of sickle cell disease
8. Beyond hemoglobin polymerization: The red cell membrane and sickle cell disease pathophysiology
9. α4β1-integrin expression of sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium
10. 1 integrin receptors on sickle reticulocytes and fibronectin
11. The endothelial biology of sickle cell disease
12. The adhesive sickle erythrocyte: Cause and consequence of abnormal interactions with endothelium, monocyte/ macrophages and model membranes
13. Thrombospondin from activated platelets promotes sickle cell erythrocyte adherence to human microvascular endothelium under physiologic flow: A Potential role for platelet activation in sickle cell vaso-occlusion
14. Sickle erythrocytes stimulated with phorbol ester adhere to endothelium via activated α4β1 integrin on sickle reticulocytes and fibronectin on endothelium
15. Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions
16. Integrin α4β1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia
17. Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombspondin under flow conditions
18. Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin
19. Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics
20. Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor
21. Adhesion of sickle red blood cells and damage to interleukin-1β stimulated endothelial cells under flow in vitro
22. Circulating endothelial cells in sickle cell anemia
23. Serum interleukin-6 levels in the steady state of sickle cell disease
24. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease
25. Elevated levels of IL-8 during sickle cell crisis
26. Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease
27. Is there an acute-phase response in steady-state sickle cell disease?
28. A Marker for tissue damage in patients with sickle cell disease
29. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of disease show enhanced adhesion to vascular endothelium and increased expression of CD64
30. Thrombospondin (TSP) mediates the adhesion of sickle erythrocytes to platelets (PLT)
31. C-Reactive protein induces human peripheral blood monocytes to synthesize tissue factor
32. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk for first myocardial infarction
33. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease
34. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease
35. Beneficial effects of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease
36. Acute-phase proteins and other systemic responses to inflammation
37. Laboratory profile of sickle cell disease: A cross-sectional analysis. The Cooperative Study of Sickle Cell Disease
38. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin
39. Prediction of adverse outcomes in children with sickle cell disease
40. Stroke in a cohort of patients with homozygous sickle cell disease
41. Factors predictive of abnormal MRI in children with sickle cell disease
42. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease
43. Hydroxyurea and phlebotomy: An alternative therapy for stroke in children with sickle cell anemia
44. Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia
45. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst
46. Perspective series: Cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium
47. Vaso-occlusive crisis-associated neutrophil dysfunction in patients with sickle cell disease
48. 2 in sickle cell disease
49. 2 levels in acute chest syndrome of sickle cell disease
50. Adhesion of sickle neutrophils and erythrocytes to fibronectin
51. Activated platelets signal chemokine synthesis by human monocytes
52. Monocyte phagocytic activity in sickle cell disease
53. Platelet activation and interaction with leukocytes in patients with sepsis and multi-organ failure
54. Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?
55. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anemia
56. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
57. Elevated fibrin D-dimer fragment in sickle cell anemia: Evidence for activation of coagulation during steady state as well as in painful crisis
58. Increased plasma levels of fragment 1.2 correlate with loss of phospholipid asymmetry in subpopulations of sickle cells
59. Tissue factor antigen and activity are not expressed on the surface of intact cells isolated from an acute promyelocytic leukemia patient
60. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay
61. Upregulation of NF-κB, tissue factor, E-selectin, and neutrophil adhesion in endothelial cells incubated with monocytes and red blood cells from sickle cell anemia patients
62. Monocyte production of intracellular tumor necrosis factor-α (TNF-α) and Interleukin-1β (IL-1β) in peripheral blood monocytes from patients with sickle cell disease (SCD)
63. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia
64. Platelet activation in patient with sickle cell disease
65. Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation
66. Platelet activation and procoagulant activity in sickle cell disease
67. Circulating platelets and red cells promote in vivo thrombogenic activity in sickle cell disease
68. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion
69. Formation of platelet-leukocyte conjugates in whole blood
70. Platelet-monocyte aggregates (PMA) in patients with sickle cell disease
71. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes
72. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia - Use in predicting clinical severity
73. s gene cluster haplotypes as genetic markers for severe disease expression
74. The variable expression of sickle cell disease is genetically determined